Leukemia & lymphomaHumansAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem Cell TransplantationMultiple MyelomaRandomized Controlled Trials as Topic
The challenge of non-transplant eligible, newly diagnosed multiple myeloma.
Ioannis Ntanasis-Stathopoulos, Eirini Solia, Charalampos Filippatos, Maria Gavriatopoulou, Evangelos Terpos
Published: 202510.1080/10428194.2025.2513676
Abstract
Eligibility for autologous transplantation is a key factor for tailoring treatment decisions in patients with newly-diagnosed multiple myeloma. For non-eligible patients, several factors determine the choice of the most appropriate therapeutic regime…
Preview only. Read the full abstract at the source